Reduced expression and promoter methylation of p16 gene in Epstein-Barr virus-associated gastric carcinoma

Japanese Journal of Cancer Research

Volumn 93, Issue 11, 2002, Pages 1195-1200

  Osawa, Toshiya ^a,b   Chong, Ja Mun ^a   Sudo, Makoto ^a,b   Sakuma, Kazuya ^a,c   Uozaki, Hiroshi ^a   Shibahara, Junji ^a   Nagai, Hideo ^c   Funata, Nobuaki ^d   Fukayama, Masashi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF YAMANASHI   (Japan)

^c JICHI MEDICAL UNIVERSITY   (Japan)

^d TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

Author keywords

Epstein Barr virus; Gastric carcinoma; Methylation; p16

Indexed keywords

PROTEIN P16;

ADULT; AGED; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PHASE TRANSITION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN METHYLATION; STATISTICAL ANALYSIS; STOMACH CARCINOGENESIS; STOMACH CARCINOMA;

EID: 0036868960     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2002.tb01223.x     Document Type: Article

References (31)

1. Fukayama, M., Chong, J.-M. and Uozaki, H. Pathology and molecular pathology of Epstein-Barr virus-associated gastric carcinoma. In "Epstein-Barr Virus and Human Cancer," ed. K. Takada, Current Topics in Microbiology and Immunology No. 258, pp. 91-102 (2001). Springer, Berlin.
2. Fukayama, M., Chong, J.-M. and Kaizaki, Y. Epstein-Barr virus and gastric carcinoma. Gastric Cancer, 1, 104-114 (1998).
3. Fukayama, M., Hayashi, Y., Iwasaki, Y., Chong, J.-M., Ooba, T., Takizawa, T., Koike, M., Mizutani, S., Miyaki, M. and Hirai, K. Epstein-Barr virus-associated gastric carcinoma and Epstein-Barr virus infection of the stomach. Lab. Invest., 71, 73-81 (1994).
4. Kaizaki, Y., Sakurai, S., Chong, J.-M. and Fukayama, M. Atrophic gastritis, Epstein-Barr virus infection, and Epstein-Barr virus-associated gastric carcinoma. Gastric Cancer, 2, 101-108 (1999).
5. Chong, J.-M., Fukayama, M., Hayashi, Y., Funata, N., Takizawa, T., Koike, M., Muraoka, M., Kikuchi-Yanoshita, R., Miyaki, M. and Mizuno, S. Expression of CD44 variants in gastric carcinoma with or without Epstein-Barr virus. Int. J. Cancer, 74, 450-454 (1997).
6. Chong, J.-M., Sakuma, K., Sudo, M., Osawa, T., Ohara, E., Uozaki, H., Shibahara, J., Kuroiwa, K., Tominaga, S., Hippo, Y., Aburatani, H., Funata, N. and Fukayama, M. Interleukin 1β expression in human gastric carcinoma with Epstein-Barr virus infection. J. Virol., 76, 6825-6831 (2002).
7. Imai, S., Koizumi, S., Sugiura, M., Tokunaga, M., Uemura, Y., Yamamoto, N., Tanaka, S., Sato, E. and Osato, T. Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proc. Natl. Acad. Sci. USA, 91, 9131-9135 (1994).
8. Chong, J.-M., Fukayama, M., Hayashi, Y., Takizawa, T., Koike, M., Konishi, M., Kikuchi-Yanoshita, R. and Miyaki, M. Microsatellite instability in the progression of gastric carcinoma. Cancer Res., 54, 4595-4597 (1994).
9. Schneider, B. G., Gulley, M. L., Eagan, P., Bravo, J. C., Mera, R. and Geradts, J. Loss of p16/CDKN2A tumor suppressor protein in gastric adenocarcinoma is associated with Epstein-Barr virus and anatomic location in the body of the stomach. Hum. Pathol., 31, 45-50 (2000).
10. Toyota, M., Ahuja, N., Suzuki, H., Itoh, F., Ohe-Toyota, M., Imai, K., Baylin, S. B. and Issa, J. P. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res., 59, 5438-5442 (1999).
11. Shim, Y. H., Kang, G. H. and Ro, J. Y. Correlation of p16 hypermethylation with the p16 protein loss in sporadic gastric carcinomas. Lab. Invest., 80, 689-695 (2000).
12. Song, H. S., Jong, H. S., Choi, H. H., Kang, S. H., Ryu, M. H., Kim, N. K., Kim, W. H. and Bang, Y. J. Methylation of specific CpG sites in the promoter region could significantly down-regulate p16(INK4a) expression in gastric adenocarcinoma. Int. J. Cancer, 87, 236-240 (2000).
13. INA4A promoter hypermethylation of non-tumorous tissue adjacent to gastric cancer is correlated with glandular atrophy and chronic inflammation. Int. J. Cancer, 93, 629-634(2001).
14. Tsujie, M., Yamamoto, H., Tomita, N., Sugita, Y., Olme, M., Sakita, I., Tamaki, Y., Sekimoto, M., Doki, Y., Inoue, M., Matsuura, N., Monden, T., Shiozaki, H. and Monden, M. Expression of tumor suppressor gene p16(INK4) products in primary gastric cancer. Oncology, 58, 126-136 (2000).
15. Kang, G. H., Lee, S., Kim, W. H., Lee, H. W., Kim, J. C., Rhyu, M.-G. and Ro, J. Y. Epstein-Barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma. Am. J. Pathol., 160, 787-794 (2002).
16. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma-2nd English edition. Gastric Cancer, 1, 10-24 (1998).
17. Lauren, R. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol. Microbiol. Scand., 64, 31-49 (1965).
18. Hermans, J. G., Graff, J. R., Myöhänen, S., Nelkin, B. D. and Baylin, S. B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA, 93, 9821-9826 (1996).
19. Kamb, A. Cell-cycle regulators and cancer. Trends Genet., 11, 136-140 (1995).
20. Bender, C. M., Pao, M. M. and Jones, P. A. Inhibition of DNA methylation by 5-aza-2′-deoxycytidine suppresses the growth of human tumor cell lines. Cancer Res., 58, 95-101 (1998).
21. Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C., Baylin, S. B. and Sidransky, D. 5′ CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers. Nat. Med., 1, 686-692 (1995).
22. Baylin, S. B., Herman, J. G., Graff, J. R., Vertino, P. M. and Issa, J. P. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv. Cancer Res., 72, 141-196 (1998).
23. Yoder, J. A., Walsh, C. and Bestor, T. H. Cytosine methylation and the ecology of intragenomic parasites. Trends Genet., 13, 335-340 (1997).
24. Allday, M. J., Kundu, D., Finerty, S. and Griffin, B. E. CpG methylation of viral DNA in EBV-associated tumours. Int. J. Cancer, 45, 1125-1130 (1990).
25. Robertson, K. D. and Ambinder, R. F. Mapping promoter regions that are hypersensitive to methylation-mediated inhibition of transcription: application of the methylation cassette assay to the Epstein-Barr virus major latency promoter. J. Virol., 71, 6445-6454 (1997).
26. Salamon, D., Takacs, M., Rjvari, D., Uhlig, J., Wolf, H., Minarovits, J. and Niller, H. H. Protein-DNA binding and CpG methylation at nucleotide resolution of latency-associated promoters Qp, Cp, and LMP1p of Epstein-Barr virus. J. Virol., 75, 2584-2596 (2001).
27. Bednarik, D. P., Cook, J. A. and Pitha, P. M. Inactivation of HIV LTR by DNA CpG methylation. EMBO J., 1, 1157-1164 (1989).
28. Saggioro, D., Panozzo, M. and Chieco-Bianchi, L. Human T-lymphotropic virus 1 transcriptional regulation by methylation. Cancer Res., 50, 4968-4973 (1990).
29. Saggioro, D., Forino, M. and Chieco-Bianchi, L. Transcriptional block of HTLV-1 LTR by sequence-specific methylation. Virology, 182, 68-75 (1991).
30. Gratama, J. W. and Ernberg, I. Molecular epidemiology of Epstein-Barr virus infection. Adv. Cancer Res., 67, 197-255 (1995).
31. Mikovits, J. A., Young, H. A., Vertino, P., Issa, J.-P. J., Pitha, P. M., Turcoski-Corrales, S., Taub, D. D., Petrow, C. L., Baylin, S. B. and Ruscetti, F. W. Infection with human immunodeficiency virus type 1 upregulates DNA methyl-transferase, resulting in de novo methylation of the gamma interferon (IFN-γ) promoter and subsequent downregulation of IFN-γ production. Mol. Cell. Biol., 18, 5166-5177 (1998).